Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avinger, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AVGR
Nasdaq
3840
avinger.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avinger, Inc.
Q3 2024 Avinger Inc Earnings Call
- Nov 8th, 2024 4:24 pm
Avinger Inc (AVGR) Q3 2024 Earnings Call Highlights: Strategic Realignment and Product Launches ...
- Nov 8th, 2024 7:28 am
Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates
- Nov 7th, 2024 10:35 pm
Avinger: Q3 Earnings Snapshot
- Nov 7th, 2024 9:26 pm
Avinger Reports Third Quarter 2024 Results
- Nov 7th, 2024 9:05 pm
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
- Oct 29th, 2024 12:00 pm
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
- Oct 24th, 2024 12:00 pm
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
- Sep 18th, 2024 12:00 pm
Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment
- Aug 21st, 2024 3:11 pm
Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device
- Aug 20th, 2024 12:30 pm
Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates
- Aug 8th, 2024 9:20 pm
Avinger: Q2 Earnings Snapshot
- Aug 8th, 2024 8:13 pm
Avinger Reports Second Quarter 2024 Results
- Aug 8th, 2024 8:01 pm
Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer
- Aug 5th, 2024 12:00 pm
Avinger to Announce Second Quarter 2024 Results on August 8, 2024
- Jul 29th, 2024 12:45 pm
Avinger Announces Closing of up to $24 Million Public Offering
- Jun 17th, 2024 8:05 pm
Avinger Announces Pricing of up to $24 Million Public Offering
- Jun 14th, 2024 12:00 pm
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
- Jun 5th, 2024 11:30 am
Are Medical Stocks Lagging Avinger (AVGR) This Year?
- May 17th, 2024 1:40 pm
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
- May 16th, 2024 8:05 pm
Scroll